Lilly once again trying to buy someone elses innovation ?

[Anonymous]

In another sign of how much (little) faith they have in their own pipeline, news has surfaced that Lilly is pursuing a takeover of troubled Ariad Pharmaceuticals, whose cancer drug Inclusig was temporarily pulled from the US market in November then reinstated with restrictions. If it happens, probably will help about as much as Imclone did.

 

[Anonymous]

Let's see, what's the conversion factor again? 5500 "Reallocated" = $1 Billion?

 

[Anonymous]

As if to say: "...our own stunning pipeline failures simply aren't enough; let's pay billions to pile on the failures of others as well..." Brilliant!

 

[Anonymous]

As if to say: "...our own stunning pipeline failures simply aren't enough; let's pay billions to pile on the failures of others as well..." Brilliant!

Seriously are you surprised ? This is what you would expect from these guys would you expect anything else !

 

[Anonymous]

Keep an eye on 2016 PUT options. When those go up, you will know the end is near

 

[Anonymous]

Keep an eye on 2016 PUT options. When those go up, you will know the end is near

Don't have to wait till 2016 check out Seeking Alpha investors are already strategizing for the take down............good bye yellow brick road

 

[Anonymous]

Don't have to wait till 2016 check out Seeking Alpha investors are already strategizing for the take down............good bye yellow brick road

Get those LEAP PUTS while the getting is good.